Mobile Menu


Pharmacoengineering is the science behind the development of materials and technologies to improve the delivery of therapeutic and diagnostic agents. Advances in this field can lead to new generations of drugs, drug delivery systems, and novel means to assess drug safety and efficacy through imaging and biosensing.

Targeted investment in pharmacoengineering within the UNC system will build on the success of medicine and life science at UNC-Chapel Hill and engineering at NC State and leverage the success of the existing joint Department of Biomedical Engineering between those institutions. The focus of this investment will be on building collaborations between UNC-Chapel Hill’s Schools of Medicine, Pharmacy, and College of Arts and Sciences, and NC State’s Colleges of Engineering, Agriculture and Life Sciences, Science, and Veterinary Medicine, as well as with private companies and nonprofits.


The Future of Therapeutics: An engineering approach for treating cancer and heart disease

  • Pharmacoengineering: Integrating Engineering with Pharmaceutical Sciences to Improve Delivery of Therapeutics
  • $1,830,000
  • July 2015 - June 2018
  • Michael Jay, PhD, Distinguished Professor and Chair of Molecular Pharmaceutics, UNC-CH
  • Frances Ligler, D.Phil., D.Sc., Distinguished Professor of Biomedical Engineering, NC State University
  • UNC-Chapel Hill
  • North Carolina State University

The Future of Vaccines: Using algae for large-scale vaccine and therapeutic production

  • Bioengineering Microalgae for Large-Scale Production of Therapeutic Antibodies Against Ebola, West Nile Virus, and Rabies
  • $600,000
  • July 2014 - June 2017
  • Led by TinChung Leung, PhD, Assistant Professor of Biology at North Carolina Central University
  • North Carolina Central Universty
  • NC Research Campus
  • North Carolina State University
  • UNC-Chapel Hill